VF
SXTPW icon

Virtu Financial’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Virtu Financial’s Portfolio SXTPW Stock Details SXTPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,020
Closed – – 2212
2025
Q3 		$0 Buy
+10,020
New +$687 ﹤0.01% 2067
2024
Q3 		– Sell
-12,174
Closed -$1K – 1868
2024
Q2 		$1K Buy
+12,174
New +$1.13K ﹤0.01% 1217
2024
Q1 		– Sell
-19,121
Closed -$1K – 2075
2023
Q4 		$1K Sell
19,121
-1,180
-6% -$149 ﹤0.01% 1507
2023
Q3 		$8K Buy
+20,301
New +$8.71K ﹤0.01% 1125

Other funds holding SXTPW

Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial's SXTPW Position: Q4 2025 in Review

Virtu Financial sold out of 60 Degrees Pharmaceuticals Warrant (SXTPW) in Q4 2025, closing a stake of 10,020 shares.

Virtu Financial first reported a position in SXTPW in Q3 2023 and held it in 4 quarters. The position peaked at $8K in Q3 2023. 8 funds tracked by Wall St. Rank hold SXTPW as of Q4 2025.

  • Virtu Financial reported no remaining 60 Degrees Pharmaceuticals Warrant position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 10,020 60 Degrees Pharmaceuticals Warrant shares in Q4 2025.
  • Virtu Financial first reported a position in 60 Degrees Pharmaceuticals Warrant in Q3 2023 and held it in 4 quarters.
  • Virtu Financial's 60 Degrees Pharmaceuticals Warrant position peaked at $8K in Q3 2023.
  • 8 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.